Accurate in directionAccuracy in direction. I started with penny stocks then forex. Through it all I stuck with reading the charts and understanding it. I've used tradeview as a diary for myself.
Key stats
Market capitalization
17.287MCAD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−6.20CAD
About AETERNA ZENTARIS INC
ISIN
CA0079755017
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
zentaris.com
CEO
Klaus Wolfgang Paulini
Headquarters
Toronto
Employees
21
Founded
1990
Æterna Zentaris, Inc. is a specialty biopharmaceutical company, which engages in the development and commercialization of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.
AEZS European approval to market MacrillenAEterna has a variety of new products in its pipeline.
Macrilen, for example, is the first and only FDA-approved oral test for the diagnosis of Adult Growth Hormone Deficiency.
AEterna received European approval to market Macrillen.
Dr. Christian Strasburger: "Clinical studies have demonstrated
$AEZSprice action : The stock should test .93 level to reach higher level. Although, 1.17 is feasible
AEZS BullishThe 9ema is crossing the 20ema and the current price is at the YTD POC line. The MACD crossed a few days ago . I would like to see it hold $1.03 for a long swing to: $1.45 and $1.87
C+H on the 1M Chart perhapsI'm a novice but looking at the 1 Month chart looks like a distinct Cup and Handle forming, thoughts???
$AEZS trend reversal Based off trend lines.
AEZS recently gained compliance
Volume has been low the last few days compared to average
Earnings to be announced on March 30th
$AEZS Target PTs 3.50-5.50-15Aeterna Zentaris Inc (NASDAQ: AEZS) has exercised its option announced on February 2, and entered into an exclusive worldwide sub-licensable patent and know-how license agreement for a potential COVID-19 vaccine.
The vaccine is currently in preclinical development and was invented at the Julius-Maxi
Aeterna Zentaris Announces Exclusive License Agreement and ReseaAEZS: Aeterna Zentaris Inc
2021-03-15 08:05:00
Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with Julius-Maximilians-University Wuerzburg for Development of a Potential Oral Prophylactic Bacterial Vaccine Against COVID-19
$AEZS Bullish Indicators Bullish Indicators
- Falling Wedge
- Wide RSI Divergence
- Aeterna Zentaris to Present at the H.C. Wainwright Global Life Sciences Conference March 9-10
AEZSAEZS .... PULLBACK ...WEDGE SISTEM RETURN AFTER PUBBLIC OFFERT..... STAY TUNED THE SAME MODEL AS CLSN ATOS......TO BE PATIENCE AND FO.LOW THE PREVISION
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0